SP-141

N/A

Report date: 2025/01/26 18:06:38
NME

Base Information

Drug NameSP-141
Drug Alias NameSP-141
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 degraders
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTexas Tech University
China Registration ClassN/A

Develop Information

Active CompaniesTexas Tech University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A